Centaurus Therapeutics
San Francisco, US
Founders & leadership
SH
Stephen HalaszExecutive Officer, Director
JB
Jeremy BlitzerExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$2MraisedJun 2022 · 1 investors · OtherRule 506(b)
▶$2MraisedJun 2022 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Stephen HalaszExecutive Officer, Director
- Jeremy BlitzerExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $2M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.